Filter content

The COVID-19 pandemic is affecting the mental health of patients hospitalized with the virus, the healthcare workers treating them, people with preexisting psychiatric issues, and the general public.

Shatterproof, the American Society of Addiction Medicine, and the proprietors of the cloud-based platform OpenBeds have combined to develop a free resource to assess the needs of an individual with addiction and provide guidance on the most appropriate type of treatment.

Keeping clients engaged in treatment is an ongoing challenge for providers, but Community Medical Services, an Arizona-based national operator of opioid treatment programs in nine states, is finding success by enticing patients to strive for rewards.

Summit BHC announced this week that it has acquired Highland Hospital, a 131-bed psychiatric facility in Charleston, West Virginia. The deal is Summit’s second acquisition of 2020, following the acquisition of an acute psychiatric and behavioral health hospital in Colorado in January.

A machine-learning model used pretreatment symptom scores and electroencephalographic measures to reliably predict patients with depression who responded to antidepressant treatment.

Psych Congress Steering Committee member and psychiatrist Rakesh Jain, MD, MPH, discusses reflections he has had during the COVID-19 pandemic about his 33 years of treating major depressive disorder.

The widespread economic impact of COVID-19 has touched all industries, including addiction treatment and behavioral health providers. Cash flow interruptions have caused some providers to consider their options, including bankruptcy and restructuring. Recently American Addiction Centers (AAC), a…

Pediatric emergency department visits for deliberate self-harm rose 329% from 2007 to 2016, according to a study published online in the journal Pediatrics.

Pinnacle Treatment Centers announced that it has opened its first in-hospital program in Ravenna, Ohio. Recovery Works Portage is a 36-bed detox unit at University Hospitals Portage Medical Center, which is about 40 miles southeast of Cleveland. The program will help patients manage withdrawal…

In a study of long-term recovery in individuals with moderate to severe opioid use disorder following their transition from two Phase 3 clinical trials of Sublocade, the extended-release formulation of buprenorphine, 44% of participants self-reported sustained illicit opioid-free weeks for the two-…